JREG:F:F-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity Fund (EUR)

ETF | Others |

Last Closing

USD 49.395

Change

+0.13 (+0.25)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.75%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.29 (-0.57%)

USD 114.13B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.26 (-0.21%)

USD 106.46B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.30 (-0.52%)

USD 100.12B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.55%)

USD 63.18B
VUAA:F Vanguard S&P 500 UCITS Acc

+1.87 (+1.73%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.15 (-0.06%)

USD 51.11B
XJSE:F Xtrackers II - Japan Governmen..

+0.07 (+0.87%)

USD 43.12B
0ZC:F Zscaler Inc

+5.56 (+3.12%)

USD 37.92B

ETFs Containing JREG:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.01% 66% D+ 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.01% 66% D+ 57% F
Trailing 12 Months  
Capital Gain 27.31% 84% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.31% 81% B- 64% D
Trailing 5 Years  
Capital Gain 88.71% 93% A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 88.71% 93% A 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 16.79% 90% A- 77% C+
Dividend Return 16.79% 88% B+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.29% 47% F 81% B-
Risk Adjusted Return 117.45% 98% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.